Correlation Between Reviva Pharmaceuticals and Neximmune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Neximmune, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Neximmune.

Diversification Opportunities for Reviva Pharmaceuticals and Neximmune

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Reviva and Neximmune is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Neximmune go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Neximmune

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 3.15 times more return on investment than Neximmune. However, Reviva Pharmaceuticals is 3.15 times more volatile than Neximmune. It trades about 0.05 of its potential returns per unit of risk. Neximmune is currently generating about 0.03 per unit of risk. If you would invest  202.00  in Reviva Pharmaceuticals Holdings on August 27, 2024 and sell it today you would lose (181.00) from holding Reviva Pharmaceuticals Holdings or give up 89.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy75.34%
ValuesDaily Returns

Reviva Pharmaceuticals Holding  vs.  Neximmune

 Performance 
       Timeline  
Reviva Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Neximmune 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Reviva Pharmaceuticals and Neximmune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reviva Pharmaceuticals and Neximmune

The main advantage of trading using opposite Reviva Pharmaceuticals and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.
The idea behind Reviva Pharmaceuticals Holdings and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios